Servizio Di Endocrinologia E Diabetologia, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.
Facoltà Di Scienze Biomediche, Università Della Svizzera Italiana (USI), Lugano, Switzerland.
Endocr Pathol. 2022 Dec;33(4):457-471. doi: 10.1007/s12022-022-09729-x. Epub 2022 Aug 31.
A thyroid nodule classified as indeterminate on fine-needle aspiration cytology (FNAC), hereafter referred to as an indeterminate thyroid nodule (ITN), represents a clinical dilemma. The Italian Consensus for the Classification and Reporting of Thyroid Cytology (ICCRTC) divides ITNs into low- and high-risk categories (i.e., TIR3A and TIR3B, respectively) to better manage patients. This study aimed to achieve high-evidence estimates of the prevalence, rate of operation, and risk of malignancy of ITNs, including TIR3A and TIR3B ITNs. This systematic review was conducted according to MOOSE to retrieve all original studies citing ICCRTC. The last search was performed in February 2022. The risk of bias of the included studies was assessed. Separate proportion meta-analyses were performed with a random-effect model using OpenMeta[Analyst]. The online search processed 271 studies, and 33 were finally considered. First, the cancer prevalence among ITNs was 32.4%. Second, the cancer prevalence among TIR3As was 12.4%, with heterogeneity (I 90%) explained by a linear correlation between sample size and cancer rate (p = 0.009). Third, the cancer prevalence among TIR3Bs was 44.4%, with heterogeneity (I 75%) explained by the inverse correlation between sample size and cancer rate (p = 0.031). Fourth, the prevalence of ITNs, TIR3A, and TIR3B among FNACs was 29.6%, 12.6%, and 12.9%, respectively, with sample size and TIR3B prevalence being inversely correlated (p = 0.04). Fifth, the operation rates of ITNs, TIR3A, and TIR3B were 54.3%, 48.3%, and 75.2%, respectively, and the sample size and TIR3A operation rate were inversely correlated (p = 0.010). These data strongly support the division of ITNs into low- and high-risk subcategories. Importantly for clinical practice, the cancer rate among ITNs is significantly influenced by the study sample size.
甲状腺细针抽吸细胞学检查(FNAC)结果不确定的甲状腺结节,以下简称不确定甲状腺结节(ITN),代表了一种临床困境。意大利甲状腺细胞病理学分类和报告共识(ICCRTC)将 ITN 分为低风险和高风险类别(即 TIR3A 和 TIR3B),以便更好地管理患者。本研究旨在获得 ITN(包括 TIR3A 和 TIR3B)的患病率、手术率和恶性肿瘤风险的高证据估计值。本系统评价按照 MOOSE 检索引用 ICCRTC 的所有原始研究。最后一次搜索于 2022 年 2 月进行。使用 OpenMeta[Analyst] 以随机效应模型进行了单独的比例荟萃分析。在线搜索处理了 271 项研究,最终考虑了 33 项研究。首先,ITN 中的癌症患病率为 32.4%。其次,TIR3A 的癌症患病率为 12.4%,异质性(I 90%)通过样本量与癌症发生率之间的线性相关性来解释(p=0.009)。第三,TIR3B 的癌症患病率为 44.4%,异质性(I 75%)通过样本量与癌症发生率之间的反比相关性来解释(p=0.031)。第四,FNAC 中 ITN、TIR3A 和 TIR3B 的患病率分别为 29.6%、12.6%和 12.9%,样本量与 TIR3B 患病率呈反比相关(p=0.04)。第五,ITN、TIR3A 和 TIR3B 的手术率分别为 54.3%、48.3%和 75.2%,样本量与 TIR3A 手术率呈反比相关(p=0.010)。这些数据强烈支持将 ITN 分为低风险和高风险亚类。对临床实践来说重要的是,ITN 中的癌症发生率受到研究样本量的显著影响。